MedTrace Logo

Safer Still (Exploratory Project 3)

NCT06558409 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-08-08

No results posted yet for this study

Summary

The long-term goal is to decrease suicide and suicidal behaviors in at-risk youth through preventative interventions. Investigators propose to develop an interactive intervention ("Safer Still") to help promote safe storage of firearms during the critical period immediately following high-risk care transitions. The objective of this study is to develop and test the Safer Still intervention as an efficient adjunct to traditional care for adolescents aged 12-17 years who are discharged from psychiatric hospitals and living in households where firearms are stored unsafely.

Conditions

  • Suicide Prevention

Interventions

BEHAVIORAL

" Safer Still " Interactive Intervention

An interactive intervention will be developed to help promote safe storage of firearms during the critical period immediately following high-risk care transitions.

OTHER

Enhanced Usual Care (EUC):

Families randomly assigned to the control condition will receive a psychological placebo that will feature an education only website developed by NCH's web design team. This website will cover warning signs for suicide, the leading methods of suicide - so that both conditions have content that features information about firearms - and locating professional help. The control website will NOT feature these three behavioral economic strategies--namely (a) multiple suggested alternatives for means restriction, (b) requests to justify inaction regarding means restriction, and (c) normative feedback about means restriction.

Sponsors & Collaborators

  • Ohio Chapter American Academy of Pediatrics

    collaborator OTHER

  • Jeff Bridge

    lead OTHER

Principal Investigators

  • Jeff Bridge, Ph.D. · Nationwide Children's Hospital

  • Jack Stevens, Ph.D. · Nationwide Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-07
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06558409 on ClinicalTrials.gov